Wallachbeth capital announces closing of bioaffinity technologies $3.25m offering

Jersey city, n.j. , may 7, 2025 /prnewswire/ -- wallachbeth capital llc, a leading provider of capital markets and institutional execution services, announced today that bioaffinity technologies, inc.  (nasdaq: biaf, biafw) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, has closed its previously announced best efforts offering of securities as described below for aggregate gross proceeds to the company of $3.25 million, before deducting agent fees and other estimated expenses payable by the company.
BIAF Ratings Summary
BIAF Quant Ranking